Exact Sciences to Participate in March Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston

    Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando

    Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.37
-3.73 (-1.50%)
AAPL  274.80
-0.45 (-0.16%)
AMD  256.28
+18.76 (7.90%)
BAC  54.16
+0.53 (0.99%)
GOOG  286.95
-4.79 (-1.64%)
META  613.80
-13.28 (-2.12%)
MSFT  507.46
-1.22 (-0.24%)
NVDA  192.58
-0.58 (-0.30%)
ORCL  227.61
-8.54 (-3.62%)
TSLA  431.18
-8.44 (-1.92%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.